News | November 14, 2012

MRI Better Than ECG at Identifying Silent Heart Attacks


Magnetic resonance imaging (MRI) is more effective than electrocardiography (ECG) at identifying "silent" heart attacks, also known as unrecognized myocardial infarctions, according to a study performed by National Institutes of Health researchers and international colleagues. Overall, the study found that silent heart attacks are more frequent than previous studies have reported, particularly in certain populations such as older adults with diabetes. Silent heart attacks appear to be much more common than those with recognized symptoms. "Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older Adults" was published Sept. 5 in the Journal of the American Medical Association.

The study involved 936 participants aged 67 to 93 years, enrolled in the Age Gene/Environment Susceptibility-Reykjavik Study (AGES). Of the participants, 670 were randomly selected and 266 were selected because they were known to have diabetes. Because 71 of the randomly selected participants also had diabetes, the overall study population consisted of 337 people who had diabetes and 599 who did not.

Cardiac MRI indicated that more participants, both with and without diabetes, had silent heart attacks (21 and 14 percent, respectively) than recognized heart attacks (11 and 9 percent, respectively). ECG was less effective, detecting silent heart attacks in only five percent of the participants in both groups. Silent heart attacks identified by cardiac MRI were associated with a higher risk of mortality during the study period, while silent heart attacks identified by ECG were not. However, participants who had either form of heart attack were significantly more likely to die than those who had neither.

The analysis also found that people with silent heart attacks displayed many cardiovascular risk factors associated with recognized heart attacks, such as high blood pressure and evidence of atherosclerosis (a disease in which plaque builds up inside the arteries). Yet, fewer study participants who had a silent heart attack were taking medications such as statins or aspirin compared with survivors of recognized heart attacks (36 vs. 73 percent).

The study authors suggest that people who may have an increased risk for silent heart attacks, such as older people with diabetes, may benefit from following cardiovascular disease prevention methods, given the high prevalence of silent heart attacks and their association with increased mortality.

This study was conducted by researchers at the National Heart, Lung, and Blood Institute; the National Institute on Aging; and the Icelandic Heart Association.

For more information: www.nih.gov


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now